Free Trial

Iradimed (IRMD) News Today

Iradimed logo
$52.96 +0.10 (+0.19%)
As of 03/25/2025 04:00 PM Eastern
Iradimed Corporation stock logo
Iradimed Corporation (NASDAQ:IRMD) Position Boosted by Magnetar Financial LLC
Magnetar Financial LLC raised its holdings in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 129.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,202 shares of the
Iradimed Corporation stock logo
HighTower Advisors LLC Has $3.30 Million Stock Position in Iradimed Corporation (NASDAQ:IRMD)
HighTower Advisors LLC decreased its stake in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 27.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 60,000 shares of the medical equipment provider's stock aft
Iradimed Corporation stock logo
16,830 Shares in Iradimed Corporation (NASDAQ:IRMD) Acquired by Proficio Capital Partners LLC
Proficio Capital Partners LLC bought a new stake in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 16,830 shares of the medical equipment provider's stock, valued at approximatel
Iradimed Corporation stock logo
Iradimed Corporation (NASDAQ:IRMD) Short Interest Update
Iradimed Corporation (NASDAQ:IRMD - Get Free Report) was the recipient of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 201,000 shares, an increase of 16.5% from the February 13th total of 172,600 shares. Currently, 2.5% of the shares of the company are sold short. Based on an average daily volume of 42,800 shares, the days-to-cover ratio is currently 4.7 days.
Iradimed Corporation stock logo
AlphaQuest LLC Has $182,000 Position in Iradimed Corporation (NASDAQ:IRMD)
AlphaQuest LLC cut its position in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 74.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,302 shares of the medical equip
Iradimed Corporation stock logo
Bank of New York Mellon Corp Has $5.51 Million Position in Iradimed Corporation (NASDAQ:IRMD)
Bank of New York Mellon Corp lifted its position in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 94.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 100,108 shares of the medical equipment provider
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Sees Strong Trading Volume - Time to Buy?
Iradimed (NASDAQ:IRMD) Sees Strong Trading Volume - Time to Buy?
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Downgraded by StockNews.com to "Buy"
StockNews.com cut shares of Iradimed from a "strong-buy" rating to a "buy" rating in a research note on Thursday.
Iradimed Corporation stock logo
Proficio Capital Partners LLC Makes New $926,000 Investment in Iradimed Corporation (NASDAQ:IRMD)
Proficio Capital Partners LLC acquired a new position in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 16,830 shares of the medical equipment provider's stock, value
Iradimed Corporation stock logo
Rhumbline Advisers Purchases 6,062 Shares of Iradimed Corporation (NASDAQ:IRMD)
Rhumbline Advisers increased its position in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 46.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 19,252 shares of the medical equipment provider's stock after a
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Downgraded by StockNews.com to Buy
StockNews.com lowered Iradimed from a "strong-buy" rating to a "buy" rating in a research report on Tuesday.
Iradimed Corporation stock logo
Los Angeles Capital Management LLC Decreases Stock Holdings in Iradimed Corporation (NASDAQ:IRMD)
Los Angeles Capital Management LLC cut its stake in Iradimed Corporation (NASDAQ:IRMD - Free Report) by 13.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,063 shares of the medical equ
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Raised to Strong-Buy at StockNews.com
StockNews.com raised shares of Iradimed from a "buy" rating to a "strong-buy" rating in a report on Friday.
Iradimed Corporation stock logo
Iradimed Corporation (NASDAQ:IRMD) Announces Dividend Increase - $0.17 Per Share
Iradimed Corporation (NASDAQ:IRMD) declared a quarterly dividend on Friday, February 14th. Stockholders of record on Monday, February 24th will be given a dividend of 0.17 per share by the medical equipment provider on Wednesday, March 5th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date is Monday, February 24th. This is a boost from Iradimed's previous quarterly dividend of $0.15.
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Receives "Buy" Rating from Roth Mkm
Roth Mkm reissued a "buy" rating and issued a $72.00 price objective (up previously from $60.00) on shares of Iradimed in a research report on Friday.
iRadimed price target raised to $72 from $60 at Roth MKM
iRadimed reports Q4 EPS 44c vs 39c last year
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Releases FY 2025 Earnings Guidance
Iradimed (NASDAQ:IRMD) updated its FY 2025 earnings guidance. The company provided EPS guidance of 1.710-1.810 for the period, compared to the consensus estimate of 1.750. The company also issued revenue guidance of $78.0 millionillion-$82.0 millionillion, compared to the consensus estimate of $80.7 millionillion.
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Updates Q1 2025 Earnings Guidance
Iradimed (NASDAQ:IRMD) updated its first quarter 2025 earnings guidance. The company provided EPS guidance of 0.390-0.430 for the period, compared to the consensus estimate of 0.410. The company also issued revenue guidance of $19.2 millionillion-$19.4 millionillion, compared to the consensus estimate of $19.1 millionillion.
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Announces Quarterly Earnings Results
Iradimed (NASDAQ:IRMD - Get Free Report) issued its quarterly earnings data on Thursday. The medical equipment provider reported $0.40 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.05). Iradimed had a return on equity of 23.99% and a net margin of 26.12%.
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Shares Gap Down on Disappointing Earnings
Iradimed (NASDAQ:IRMD) Shares Gap Down Following Weak Earnings
Iradimed Corporation stock logo
StockNews.com Downgrades Iradimed (NASDAQ:IRMD) to Buy
StockNews.com lowered shares of Iradimed from a "strong-buy" rating to a "buy" rating in a research note on Thursday.
Iradimed Corporation stock logo
Iradimed (IRMD) Projected to Post Quarterly Earnings on Thursday
Iradimed (NASDAQ:IRMD) will be releasing earnings before the market opens on Thursday, February 13, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=517354)
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Reaches New 52-Week High - Still a Buy?
Iradimed (NASDAQ:IRMD) Reaches New 12-Month High - What's Next?
Iradimed Corporation stock logo
Iradimed Corporation (NASDAQ:IRMD) Short Interest Up 18.2% in January
Iradimed Corporation (NASDAQ:IRMD - Get Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totalling 124,100 shares, a growth of 18.2% from the December 31st total of 105,000 shares. Based on an average daily volume of 39,400 shares, the short-interest ratio is presently 3.1 days. Approximately 1.6% of the company's shares are sold short.
Iradimed Corporation stock logo
Copeland Capital Management LLC Increases Stock Holdings in Iradimed Corporation (NASDAQ:IRMD)
Copeland Capital Management LLC boosted its position in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 12.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 475,563 shares of the medical equipment provider's stock after acquiring
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Upgraded by StockNews.com to "Strong-Buy" Rating
StockNews.com raised Iradimed from a "buy" rating to a "strong-buy" rating in a research report on Tuesday.
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Hits New 52-Week High - What's Next?
Iradimed (NASDAQ:IRMD) Reaches New 12-Month High - Still a Buy?
Iradimed Corporation stock logo
JPMorgan Chase & Co. Buys 12,051 Shares of Iradimed Corporation (NASDAQ:IRMD)
JPMorgan Chase & Co. boosted its stake in Iradimed Corporation (NASDAQ:IRMD - Free Report) by 70.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,226 shares of the medical equipment provider's stock
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Hits New 1-Year High - Still a Buy?
Iradimed (NASDAQ:IRMD) Reaches New 1-Year High - Time to Buy?
Iradimed Corporation stock logo
Iradimed (NASDAQ:IRMD) Sets New 12-Month High - What's Next?
Iradimed (NASDAQ:IRMD) Hits New 52-Week High - What's Next?
Iradimed Corporation stock logo
Barclays PLC Boosts Stake in Iradimed Corporation (NASDAQ:IRMD)
Barclays PLC increased its stake in Iradimed Corporation (NASDAQ:IRMD - Free Report) by 113.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,774 shares of the medical equipment provider's stock after pur
Iradimed (IRMD) Gets a Buy from Lake Street
Iradimed Reports Growth In Q4, FY Preliminary Revenues
iRadimed reports preliminary Q4 revenue $19.2M-$19.4M
Iradimed Corporation stock logo
Iradimed Corporation (NASDAQ:IRMD) Sees Significant Growth in Short Interest
Iradimed Corporation (NASDAQ:IRMD - Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 105,000 shares, an increase of 22.0% from the November 30th total of 86,100 shares. Currently, 1.3% of the company's stock are short sold. Based on an average trading volume of 39,100 shares, the days-to-cover ratio is presently 2.7 days.
Iradimed Corporation stock logo
Barclays PLC Has $1.20 Million Stake in Iradimed Corporation (NASDAQ:IRMD)
Barclays PLC lifted its stake in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 113.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,774 shares of the medical equipment provider's stock after purchasing
Remove Ads
Get Iradimed News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.

IRMD Media Mentions By Week

IRMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IRMD
News Sentiment

1.24

0.70

Average
Medical
News Sentiment

IRMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IRMD Articles
This Week

6

2

IRMD Articles
Average Week

Remove Ads
Get Iradimed News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:IRMD) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners